Show
Sort by
-
Phase Ia study of MIDRIX4-LUNG, a tetravalent autologous dendritic cell immunotherapy, in patients with metastatic non-small cell lung cancer
-
Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC : EORTC 22113-08113 LungTech phase II trial results
-
MIDRIXNEO-LUNG : safety and immunogenicity of a neoantigen-presenting autologous dendritic cell therapy in resected NSCLC patients
(2023) JOURNAL OF THORACIC ONCOLOGY. In Journal of Thoracic Oncology 18(11, Supplement). p.S526-S526 -
- Journal Article
- A1
- open access
The International Association for the Study of Lung Cancer lung cancer staging project : overview of challenges and opportunities in revising the nodal classification of lung cancer
-
Why did the randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC not reveal a difference?
-
- Journal Article
- A1
- open access
Reaction on the interpretation of the hippocampus avoidance prophylactic cranial irradiation trial in SCLC (NCT01780675)
-
Phase 3 randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675)
-
Real-world neurocognitive function in lung cancer : initial results of the PRO-Long study.
-
Definition of synchronous oligometastatic non–small cell lung cancer : a consensus report
-
Health-related quality of life in KEYNOTE-010 : a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1-expressing NSCLC (vol 14, pg 793, 2019)